Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-06-30 View official record Methodology

Covered recipient · General Payments record

JAMES P EICHELBERGER

Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease

NPI
1255373056
CMS profile
11851
Location
ROCHESTER, NY

General Payments · PY2019–2023

$331,545.00

  • Reported across 48 records
  • CMS publication 2026-06-30

Latest program year · PY2023

$275,296.00

18 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2023 · sorted by reported total

By paying entity

PY2023 · sorted by reported total

Paying entityAmountRecords
Boehringer Ingelheim Pharmaceuticals, Inc. $275,296.00 18

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $1,569.00 12
PY2021 $25,000.00 8
PY2022 $29,680.00 10
PY2023 $275,296.00 18

Payment records · PY2023 (18)

Sorted by paying entity, then date · as published by CMS

Program year 2023 201920212022 Record-level detail is published for PY2023; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Boehringer Ingelheim Pharmaceuticals, Inc. $23,184.00 01/01/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 06/30/2026 1155206488 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $1,344.00 01/01/2023 Consulting Fee Undisputed 06/30/2026 996430393 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $22,400.00 02/01/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 06/30/2026 1155206486 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $1,120.00 02/01/2023 Consulting Fee Undisputed 06/30/2026 996430401 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $7,504.00 03/01/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 06/30/2026 1155206490 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $448.00 04/01/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 06/30/2026 1155206492 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $14,560.00 05/01/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 06/30/2026 1155206494 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $5,712.00 06/01/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 06/30/2026 1155206496 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $224.00 06/01/2023 Consulting Fee Undisputed 06/30/2026 997064653 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $26,208.00 07/01/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 06/30/2026 1155206498 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $224.00 07/01/2023 Consulting Fee Undisputed 06/30/2026 996430409 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $23,856.00 08/01/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 06/30/2026 1155206476 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $224.00 08/01/2023 Consulting Fee Undisputed 06/30/2026 996430405 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $29,344.00 09/01/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 06/30/2026 1155206478 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $35,952.00 10/01/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 06/30/2026 1155206480 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $32,144.00 11/01/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 06/30/2026 1155206482 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $896.00 11/01/2023 Consulting Fee Undisputed 06/30/2026 996430397 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $49,952.00 12/01/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 06/30/2026 1155206484 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2021, 2022, 2023
Source files
Dataset page · Bulk file · PY2019 , PY2021 , PY2022 , PY2023
Generated from
OP_DTL_GNRL_PGYR2023_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.